GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) LOCUS

被引：4

作者：

DAWSON, S

HAMSTEN, A

WIMAN, B

HENNEY, A

HUMPHRIES, S

机构：

[1] KING GUSTAF V RES INST,STOCKHOLM,SWEDEN

[2] KAROLINSKA HOSP,DEPT INTERNAL MED,S-10401 STOCKHOLM 60,SWEDEN

[3] KAROLINSKA HOSP,DEPT CLIN CHEM,S-10401 STOCKHOLM 60,SWEDEN

来源：

FIBRINOLYSIS | 1990年 / 4卷

关键词：

DNA; Fibrinolysis; Genetic variation; Myocardial infarction; Plasminogen activator inhibitor-1; RFLP;

D O I：

10.1016/0268-9499(90)90357-P

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A marker for genetic variation at the PAI-1 locus was used to assess the contribution of genetic variation to between individual variances in plasma PAI-1 activity. This was done for two samples, a group of 107 young myocardial infarction patients and a group of 95 controls. © 1990.

引用

页码：51 / 53

页数：3

共 30 条

[1]

ALESSI MC, 1988, THROMB HAEMOSTASIS, V60, P491

[2] TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS [J].